FDA Finalizes on Controlled Correspondence

FDA Finalizes on Controlled Correspondence

The US Food and Drug Administration (FDA) has finalized its guidance to generic drug manufacturers on how to seek drug development information through the controlled correspondence process. The guidance incorporates changes that were part of the reauthorization of the...
FDA Fires Warning on Sex and Weight Products

FDA Fires Warning on Sex and Weight Products

The FDA fired fresh consumer warning on tainted male sex enhancement and weight-loss products sold on Amazon and eBay showcases FDA’s ongoing frustrations with undeclared ingredients, including pharmaceuticals. Despite a long list of warnings over the years about...
Musclegen Guilty for SARMs Distribution

Musclegen Guilty for SARMs Distribution

The owner of a North Carolina-based sports supplement company Musclegen pleaded guilty to selling unapproved drugs and agreed to forfeit the money earned from the illegal business. Selective androgen receptor modulators (SARMs) are drugs under development for...
COVID-19 Drives Demand for Immune-Boosters

COVID-19 Drives Demand for Immune-Boosters

As COVID-19 drives continued demand for immune booster dietary supplements, new disruptions in the supply chain emphasize the need for quality assurance. The COVID-19 pandemic has been an accelerator for the dietary supplement industry, with sales at record-breaking...